Company Monitoring Page for Orexigen

latest headlines for company on cafepharma

Arena Pharma Will Fail: Hedge Fund Poll
TheStreet.com
Fri, 09/10/10 - 09:32 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Qnexa, Contrave, Orexigen
Arena Pharma: Understanding the Market for Anti-Obesity Drugs
Seeking Alpha
Fri, 09/3/10 - 11:57 am
Tags:
Arena Pharmaceuticals, Contrave, Orexigen, Vivus, obesity, Qnexa
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
Tags:
diet drugs, biotech, Arena Pharmaceuticals, Dendreon, Provenge, Exelixis, Vivus, Orexigen, Takeda, Contrave, Martek
Orexigen, Takeda Tie Knot on Obesity Drug
TheStreet.com
Thu, 09/2/10 - 08:18 am
Tags:
Orexigen, Takeda, obesity, Contrave, partnerships
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
Tags:
FDA, Questcor Pharmaceuticals, Savient, Alkermes, Arena Pharmaceuticals, Roche, Novartis, Hospira, Human Genome, Alexza, Jazz Pharmaceuticals, Biodel, Amylin, Eli Lilly, Vivus, Avanir, Cadence Pharmaceuticals, Amgen, Cumberland, Orexigen, MannKind, Bristol-Myers Squibb
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Seeking Alpha
Fri, 08/27/10 - 11:10 am
Tags:
Arena Pharmaceuticals, obesity, FDA, Vivus, Orexigen, Contrave, Qnexa
Investors Eye Stem Cell Shares Amid Court Dispute
Yahoo/IndieResearch
Thu, 08/26/10 - 09:29 am
Tags:
investors, stem cells, Aastrom, Athersys, Cytori, Opexa, Orexigen
Which biotechs are the least efficient?
Fierce Biotech
Fri, 08/20/10 - 12:53 pm
Tags:
MannKind, Orexigen, Aastrom, Hemispherx, Cell Therapeutics
Arena's Obesity Drug Likely to Pass FDA Panel With Flying Colors
Seeking Alpha
Mon, 08/9/10 - 09:46 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Orexigen, Contrave, Qnexa, FDA
Vivus slides after analyst downgrades to 'Sell'
Yahoo/AP
Tue, 08/3/10 - 07:01 pm
Tags:
Vivus, downgrades, obesity, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
Orexigen Steps Up Pace in Obesity Drug Race
Seeking Alpha
Sun, 08/1/10 - 02:47 pm
Tags:
Orexigen, Arena Pharmaceuticals, Vivus, Contrave, Qnexa
Orexigen's Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight in Study
Bloomberg
Fri, 07/30/10 - 11:05 am
Tags:
Orexigen, obesity, Contrave, Vivus, Arena Pharmaceuticals
Vivus's Obesity Drug Raises Familiar Questions
Seeking Alpha
Mon, 07/26/10 - 11:16 am
Tags:
Vivus, obesity, Arena Pharmaceuticals, Contrave, Orexigen, Qnexa
Safety Concerns May Sink Both Vivus and Its Obesity Drug Qnexa
BNET Pharma
Wed, 07/21/10 - 03:55 pm
Tags:
obesity, Vivus, Qnexa, FDA, Arena Pharmaceuticals, Contrave, Orexigen
Lessons Learned About the Outlook for New Obesity Drug Approval
Motley Fool
Sun, 07/18/10 - 07:43 am
Tags:
obesity, Arena Pharmaceuticals, Vivus, Qnexa, Contrave, Orexigen
Vivus tanks, Arena rallies on FDA diet-drug vote
Marketwatch
Fri, 07/16/10 - 10:05 am
Tags:
Vivus, Arena Pharmaceuticals, FDA, Orexigen, Contrave, Qnexa
Vivus: What Happens Next?
TheStreet.com
Fri, 07/16/10 - 08:21 am
Tags:
Vivus, Qnexa, obesity, Contrave, Arena Pharmaceuticals, Orexigen, FDA
FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
WSJ Online
Thu, 07/15/10 - 06:04 pm
Tags:
FDA, obesity, Vivus, Qnexa, advisory panels, Orexigen, Arena Pharmaceuticals, Contrave
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Yahoo/AP
Thu, 07/15/10 - 10:19 am
Tags:
obesity, Arena Pharmaceuticals, Qnexa, Contrave, Orexigen, Vivus
Live Blog--Vivus' FDA Advisory Panel
TheStreet.com
Thu, 07/15/10 - 09:05 am
Tags:
Vivus, Orexigen, obesity, FDA, Arena Pharmaceuticals, advisory panels, Qnexa

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.